ICG Enterprise Trust posted strong 15% EBITDA growth with improving margins and realisation proceeds already ahead of last year. Hardman & Co’s Mark Thomas breaks down the trust’s recent performance and outlook...
Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...
ICG Enterprise Trust posted strong 15% EBITDA growth with improving margins and realisation proceeds already ahead of last year. Hardman & Co’s Mark Thomas breaks down the trust’s recent performance and outlook...
Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...
